Bank of New York Mellon Corp - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 65 filers reported holding ENZO BIOCHEM INC in Q3 2021. The put-call ratio across all filers is 3.06 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$36,703
-23.9%
26,2170.0%0.00%
Q2 2023$48,239
-24.3%
26,2170.0%0.00%
Q1 2023$63,707
+69.9%
26,2170.0%0.00%
Q4 2022$37,490
-80.7%
26,217
-70.0%
0.00%
Q3 2022$194,000
+10.2%
87,281
+2.3%
0.00%
Q2 2022$176,000
-32.6%
85,283
-5.4%
0.00%
Q1 2022$261,000
-4.4%
90,158
+6.3%
0.00%
Q4 2021$273,000
+181.4%
84,830
+210.6%
0.00%
Q3 2021$97,000
+11.5%
27,3080.0%0.00%
Q2 2021$87,000
-83.6%
27,308
-82.3%
0.00%
Q1 2021$531,000
+36.9%
154,611
+0.4%
0.00%
Q4 2020$388,000
+13.1%
153,928
-5.5%
0.00%
Q3 2020$343,000
-32.5%
162,863
-28.3%
0.00%
Q2 2020$508,000
-11.7%
227,115
+0.0%
0.00%
Q1 2020$575,000
-8.6%
227,114
-5.0%
0.00%
Q4 2019$629,000
-27.5%
238,993
-0.9%
0.00%
Q3 2019$867,000
+3.3%
241,091
-3.2%
0.00%
Q2 2019$839,000
+37.3%
249,095
+11.3%
0.00%
Q1 2019$611,000
+0.3%
223,892
+2.3%
0.00%
Q4 2018$609,000
-28.4%
218,918
+6.0%
0.00%
Q3 2018$850,000
-20.7%
206,547
-0.0%
0.00%
Q2 2018$1,072,000
-10.9%
206,548
-6.0%
0.00%
Q1 2018$1,203,000
-30.9%
219,631
+2.8%
0.00%
Q4 2017$1,741,000
-28.2%
213,585
-7.8%
0.00%
-100.0%
Q3 2017$2,426,000
-0.7%
231,653
+4.7%
0.00%0.0%
Q2 2017$2,442,000
+41.3%
221,166
+7.1%
0.00%
Q1 2017$1,728,000
+22.0%
206,447
+1.2%
0.00%
Q4 2016$1,416,000
+56.8%
204,038
+15.0%
0.00%
Q3 2016$903,000
-19.3%
177,350
-5.3%
0.00%
Q2 2016$1,119,000
+149.2%
187,262
+89.8%
0.00%
Q1 2016$449,000
+1.1%
98,6600.0%0.00%
Q4 2015$444,000
+41.9%
98,6600.0%0.00%
Q3 2015$313,000
+4.7%
98,6600.0%0.00%
Q2 2015$299,000
-33.8%
98,660
-35.7%
0.00%
Q1 2015$452,000
-39.7%
153,408
-9.2%
0.00%
Q4 2014$750,000
-21.5%
168,926
-9.0%
0.00%
Q3 2014$956,000
-50.7%
185,637
-49.8%
0.00%
Q2 2014$1,940,000
+459.1%
369,554
+342.8%
0.00%
Q1 2014$347,000
+3.9%
83,457
-27.0%
0.00%
Q4 2013$334,000
-42.0%
114,366
-50.0%
0.00%
Q3 2013$576,000
+121.5%
228,910
+82.9%
0.00%
Q2 2013$260,000125,1570.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders